新股消息 | 百普赛斯递表港交所

Group 1 - The core viewpoint of the news is that Beijing Baipusi Biotechnology Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with CMB International as its sole sponsor [1] - Baipusi is a global provider of life science tools and technology services, focusing on empowering biopharmaceutical companies across the entire value chain of research and development, production, and clinical applications [1] - According to Frost & Sullivan, Baipusi ranks first among all domestic suppliers in China and third globally in the recombinant protein market based on revenue projected for 2024 [1]